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Rifampicin resistance (Rifr) mutations in the RNA polymerase β subunit (rpoB) gene
exhibit pleiotropic phenotypes as a result of their effects on the transcription machinery
in prokaryotes. However, the differences in the effects of the mutations on the physiology
and metabolism of the bacteria remain unknown. In this study, we isolated seven Rifr
mutations in rpoB, including six single point mutations (H485Y, H485C, H485D, H485R,
Q472R, and S490L) and one double point mutation (S490L/S617F) from vegetative
cells of an endophytic strain, Bacillus velezensis CC09. Compared to the wild-type
(WT) strain (CC09), the H485R and H485D mutants exhibited a higher degree of
inhibition of Aspergillus niger spore germination, while the H485Y, S490L, Q472R,
and S490L/S617F mutants exhibited a lower degree of inhibition due to their lower
production of the antibiotic iturin A. These mutants all exhibited defective phenotypes in
terms of pellicle formation, sporulation, and swarming motility. A hierarchical clustering
analysis of the observed phenotypes indicated that the four mutations involving amino
acid substitutions at H485 in RpoB belonged to the same cluster. In contrast, the S490L
and Q472R mutations, as well as the WT strain, were in another cluster, indicating a
functional connection between the mutations in B. velezensis and phenotypic changes.
Our data suggest that Rifr mutations cannot only be used to study transcriptional
regulation mechanisms, but can also serve as a tool to increase the production of
bioactive metabolites in B. velezensis.
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INTRODUCTION
DNA-dependent RNA polymerase (RNAP) is an enzyme that is essential to life. The core of the
bacterial RNAP consists of five subunits (α2ββ′ω). The RNAP associates with the transcription
initiation factor, σ, to form the RNAP holoenzyme (Ebright, 2000). The antibiotic rifampicin, which
is used to treat multiple types of bacterial infections, exerts its effect by inhibiting RNAP. The crystal
structure and genetic and biochemical data suggest that rifampicin binds to RNAP at a site adjacent
to its active center, thereby physically blocking the formation of phosphodiester bonds in the RNA
backbone. Rifampicin inhibits any RNA extension greater than two or three nucleotides (Campbell
and Holt, 2001).
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Resistance to rifampicin (Rifr) arises from mutations in
the rpoB gene, which encodes the β subunit of RNAP. These
mutations decrease the affinity of RNAP for rifampicin (Xu et al.,
2005). In Escherichia coli, the majority of resistance mutations
in the RpoB protein are located in three clusters. Cluster I
comprises amino acids (aa) 507–533, cluster II comprises aa
563–572, and cluster III comprises aa 687 (Jin and Gross, 1988;
Goldstein, 2014). Homologous mutations to those in E. coli have
been observed in the RpoB protein of many other bacteria,
such as Mycobacterium tuberculosis, Bacillus subtilis, Neisseria
meningitidis, Staphylococcus aureus, and Streptomyces coelicolor
(Alifano et al., 2015). The majority of the identified mutations are
in the cluster I region of RpoB (Goldstein, 2014).
Rifr mutations have pleiotropic phenotypes due to their effects
on transcription (Jin et al., 1988a,b; Maughan et al., 2004). For
instance, the Rifr mutations S531F, 1532A, L533P, and T563P in
RpoB of E. coli lead to a hyper-temperature-sensitive phenotype
in dnaA46 and rpoD800 backgrounds (Jin and Gross, 1991; Zhou
and Jin, 1997). In addition, the Rifr mutations Q469R, H482R,
and S487L in B. subtilis have global effects on growth rate,
competence for transformation, sporulation, and germination
(Maughan et al., 2004; Perkins and Nicholson, 2008). Moreover,
the Rifr mutations S442L and H437R in Streptomyces spp. lead
to a stringent response and an increase in antibiotic production
(Hu et al., 2002). Therefore, Rifr mutations have been used to
better understand the regulatory mechanisms that are underlying
bacterial physiology and virulence, and to manipulate gene
expression (for strain improvement and drug discovery) in
bacterial species that are of industrial interest (Alifano et al.,
2015).
Bacillus velezensis is a relatively novel species. It was first
described by Wang L.T. et al. (2008) as a heterotypic synonym
of Bacillus amyloliquefaciens. Recently, based on comparative
genomics and DNA relatedness calculations, B. amyloliquefaciens
subsp. plantarum, Bacillus methylotrophicus, and Bacillus
oryzicola were reclassified as heterotypic synonyms of
B. velezensis (Dunlap et al., 2015). The distinctive characteristics
of B. velezensis include methanol utilization, plant growth
promotion, and biocontrol capacity (as a result of the production
of multiple antibiotics) (Dunlap et al., 2015). Although, extensive
research has been conducted on this species to increase its
production of bioactive metabolites (Koumoutsi et al., 2007;
Jha et al., 2016; Suthar and Nerurkar, 2016) and/or plant
colonization capacity (Wang et al., 2014), it remains unclear
whether its biocontrol capacity can be enhanced by mutating
the global transcription machinery, RNAP, to produce beneficial
biocontrol phenotypes.
In this study, we obtained seven spontaneous mutations in
rpoB that confer resistance to rifampicin in an endophytic strain
of B. velezensis, CC09. This strain produces the non-ribosomal
peptide iturin A (a secondary metabolite with antibacterial and
antifungal properties), and it exhibits broad antifungal activity
against several phytopathogens, including Glomerella glycines,
Rhizoctonia solani, and Alternaria alternata (Cai et al., 2013; Yang
et al., 2014). We also evaluated the effects of these mutations on
cell growth, pellicle formation, swarming motility, sporulation,
and iturin A production.
MATERIALS AND METHODS
Bacterial Strains and Media
The strain used in this study was B. velezensis CC09, which
was previously isolated from an evergreen tree, Cinnamomum
camphora, and deposited in the China General Microbiological
Culture Collection Center (CGMCC no. 4669).
The medium used for B. velezensis cultivation was either
Luria-Bertani (LB) medium (5 g/L yeast extract, 10 g/L tryptone,
and 10 g/L NaCl; pH 7.0) or Gailiang LB (GLB) medium (3.75 g/L
yeast extract, 11.25 g/L tryptone, 5 g/L starch, and 1 g/L NaCl;
pH 7.0). The medium used for the fungi was potato-sucrose (PS)
medium (200 g/L potato and 20 g/L sucrose). The solid media
were prepared by adding 7–20 g/L agar to the liquid media.
Screening of Rifr Mutants and Mapping
of the Mutations in the rpoB Gene
The wild-type (WT) strain was cultured overnight and spread on
LB agar plates (200 µL/plate) containing 50 µg/mL rifampicin.
The plates were incubated at 37◦C for 48 h to generate
spontaneous Rifr mutants. The mutants were cultured in the LB
medium containing rifampicin and then stored at−80◦C.
Three pairs of primers (Supplementary Table S1) were used
for PCR amplification of the rpoB gene. The samples were
initially denatured at 94◦C for 5 min, followed by 30 cycles
of denaturation at 94◦C for 30 s, annealing at 55◦C for 30 s,
extension at 72◦C for 2 min, and a final extension at 72◦C for
10 min. The PCR products were purified using Axygen AxyPrep
Mag PCR Clean-Up Kits (Axygen Biosciences, Inc., Union City,
CA, USA), sequenced by BGI (Shenzhen, China), and analyzed
using BioEdit software (Hall, 1999) to identify the mutations in
rpoB.
Allelic Replacement Associated with the
Point Mutations in B. velezensis CC09
To verify that the rpoB mutations identified in B. velezensis
were sufficient to cause the Rifr phenotypic change, the
following experiments were performed. First, chromosomal DNA
from six strains with single point mutation (H485Y, H485C,
H485D, H485R, Q472R, S490L) and one strain with double
point mutation (S490L/S617F) was prepared, and then it was
amplified using PCR with the primer pair PMRif1/PMRif2
(Supplementary Table S2) flanking the mutated nucleotide,
including upstream (∼800 bp) and downstream (∼1000 bp)
sequences (Supplementary Figure S1).
For each mutation, the PCR product was ligated to a
pMAD vector (a temperature-sensitive integrative plasmid) that
had been digested by EcoR I/Bgl II using an In-Fusion HD
Cloning Kit (Clontech Laboratories, Inc., Mountain View, CA,
USA) (Sleight et al., 2010). The constructed plasmid, pMADrif,
was introduced into competent cells of the WT strain by
electroporation. Transformants were obtained after 12 h at
30◦C on LB plates containing 5 µg/mL erythromycin. A pool
of individual clones was cultured at 40◦C in the LB medium
containing the same concentration of erythromycin that used in
the stationary phase. Two more cycles of growth were carried out
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by diluting the stationary phase culture into antibiotic-free fresh
LB medium (Arnaud et al., 2004). Finally, single colonies were
obtained by plating the diluted culture onto LB agar plates free
of antibiotics. The bacteria were further screened using a replica
plating technique with LB agar plates containing antibiotics
(erythromycin or rifampicin) to obtain erythromycin-sensitive
but rifampicin-resistant colonies. The colonies were confirmed
by sequencing. Regarding the S617F mutation (phenylalanine
instead of serine) at 1849 bp that was associated with the double
mutant, the mutation was prepared using PCR with two primer
pairs (PMRif1/PMRif3 and PMRif4/PMRif2) (Supplementary
Table S2). The mutation was cloned into a pMAD vector that was
subsequently introduced into competent WT cells.
Determination of Minimum Inhibitory
Concentration (MIC)
For each mutant, the minimum inhibitory concentration (MIC)
of rifampicin was measured using a previously described method
(Clinical and Laboratory Standards Institute [CLSI], 2012).
Observation of Multicellular Growth
Pattern
The WT strain and Rifr mutants were cultured overnight.
Subsequently, 1 mL of each culture was centrifuged at 14,940× g
for 10 min. For each strain, the pellet was resuspended in
an appropriate amount of phosphate buffer (pH 7.0) to reach
a concentration of approximately 1 × 108 cells/mL. The
resuspended cells were placed at the center of GLB plates
(5 µL/plate) containing 2% agar. The plates were incubated at
32◦C for 24 h. The multicellular growth pattern of each mutant
was photographed.
Measurements of Growth Rate, Swarm
Motility, and Sporulation
The vegetative cells of the WT strain and Rifr mutants were
cultured in liquid GLB at a temperature of 32◦C and a rotational
speed of 120 rpm for 10 h for use in the following experiments.
Growth Rate
To assess the growth rate, 1% (vol/vol) of the culture was
inoculated in 100 mL GLB at 32◦C and 120 rpm in a 250-mL flask
for 26 h. In order to plot a growth curve, 1 mL of the culture was
taken every 30 min, and the optical density at 600 nm (OD600)
was measured using a spectrophotometer (GENESYS 10S UV-
Vis Spectrophotometer, Thermo Fisher Scientific, Inc., Madison,
WI, USA). The specific growth rate (µ) was calculated using the
following formula: µ = 2.303(lgOD2−lgOD1)(t2−t1)
where µ represents the specific growth rate, and OD2 and OD1
represent the OD of the culture at sampling time t2 and t1,
respectively.
Swarming Motility
To assess swarming motility, 5µL of the culture was placed in the
center of GLB plate containing 0.7% agar, followed by incubation
at 32◦C for 5 h. The swarming diameter was then measured.
The mean swarming rate (mm/h) was calculated by dividing the
swarming diameter (mm) by 5 (h) (Kearns and Losick, 2003).
Sporulation
To assess sporulation, the cell culture conditions that were
used for the growth curve analysis were replicated. After
26 h, the numbers of spores inside and outside the cells
(that were related to the vegetative cells) were counted using
a hemocytometer (model XB-K-25, Shanghai Anxin Optical
Instrument Manufacture, Co., Ltd, Shanghai, China) (Schaeffer
et al., 1965). For each strain, three replicates were performed and
a sporulation curve was plotted. The number of hours to 50%
sporulation (S50) was calculated based on the sporulation curve.
Determination of Inhibitory Activity
against Fungal Spore Germination
For each strain, the ability of the culture filtrate to inhibit the
germination of Aspergillus niger spores was assessed. Inhibition
was calculated as the ratio of the number of colonies on the
plates in the presence of the filtrate to the number of colonies
in the absence of the filtrate. Culturing was carried out at 28◦C
for 2 days, based on a previously described method (Yang et al.,
2014).
Quantification of Iturin A
Approximately, 1% (vol/vol) of the overnight culture of each
strain was inoculated in 50 mL GLB medium in a 250-mL
flask at 32◦C and 120 rpm for 48 h. Subsequently, 1 mL of
the cell suspension was centrifuged at 14,940 × g for 10 min.
The resultant supernatant was analyzed using high-performance
liquid chromatography (HPLC), following a previously described
method (Cai et al., 2013).
Observation of Pellicle Formation
For each strain, the formation of pellicle was evaluated based
on the method proposed by López and Kolter (2010). Briefly,
overnight culture was centrifuged at 14,940 × g for 10 min. The
pellet was resuspended in GLB to reach a concentration of 1× 108
cells/mL. The resuspended cells were added (1%, vol/vol) to 3 mL
sterile GLB medium in the wells of a 12-well tissue culture plate.
The cells were incubated at 32◦C for 16 h to observe whether
pellicle developed, and, if so, its appearance.
The pellicle weight was assessed in terms of its dry
weight using a digital weighing balance (Sartorius TE1502S
Talent Analytical Balance, Sartorius AG, Göttingen, Germany)
according to a previously described method (Graba et al., 2013).
Briefly, the pellicle was carefully harvested from each well using
sterile pipette tips, rinsed gently with sterile distilled water, dried
in an oven at 120◦C until the weight stopped decreasing, and
finally weighed using the digital balance.
Quantitative Real-Time PCR (RT-qPCR)
Analysis
Based on their antifungal activity, three strains were selected for
RT-qPCR analysis: CC09, CC09-RIF5, and CC09-RIF3, that is,
the WT strain, the S490L mutant (which exhibited decreased
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iturin A production), and the H485R mutant (which exhibited
increased iturin A production), respectively. The strains were
grown in GLB medium at 32◦C until the pellicle was completely
formed (16 h). Cells were harvested by centrifugation at
14,940 × g for 1 min and stored in liquid nitrogen. The total
RNA was extracted using Invitrogen TRIzol Reagent (Thermo
Fisher Scientific, Inc., USA). Reverse transcription was used to
synthesize cDNA using a random primer from the TaKaRa RT-
PCR Kit, D6110A (TaKaRa Bio, Inc., Kusatsu, Japan).
Sixteen B. velezensis CC09-specific genes were amplified: 15
that encode proteins associated with antibiotic production and
pellicle formation, and the gene that encodes ribosomal 16S RNA
(as the internal reference). The primers used for the amplification
of the genes were designed according to the genome sequence
of B. velezensis CC09 (GenBank no. CP015443) (Cai et al., 2016)
(Supplementary Table S3).
For each mutant, the fold-change in the expression of each
gene was calculated by dividing the value for the mutant
by the value for the WT strain using a previously described
method (Schmittgen and Livak, 2008). A fold-change >2- or
<0.5 compared to the WT strain was considered to represent a
significant degree of differential expression. The set of samples
for each strain involved three biological and two technical
replicates.
Data Analysis
GraphPad Prism version 3.02 (GraphPad Software, Inc., San
Diego, CA, USA, www.graphpad.com) software was used to
assess the significance of the differences using one-way analysis
of variance (ANOVA) and Tukey’s multiple comparison test
(p < 0.05 was considered statistically significant). A dendrogram
of hierarchical clustering was used to illustrate the possible
correlation between the mutations in rpoB and the phenotypic
changes using an R package for weighted correlation network
analysis (Langfelder and Horvath, 2008).
RESULTS
Spectrum of Rifr Mutations in the
B. velezensis rpoB Gene
A total of 14 spontaneous Rifr mutants were isolated by plating
the WT strain in plates containing rifampicin. Among these,
we identified seven unique mutations in the rpoB gene. Four of
the mutants (0901, 0926, 0928, and 0933) had mutations that
were located at the same site in RpoB, at aa 485. These four
mutations involved substitutions of histidine (H) for tyrosine (Y),
cysteine (C), arginine (R), and aspartic acid (D), respectively.
The mutation in the 0917 mutant was located at aa 490, and
involved a substitution of serine (S) for leucine (L) (S490L),
and the mutations in the 0943 mutant was located at aa 472,
and involved a substitution of glutamate (Q) for arginine (R)
(Q472R). The 0954 mutant had mutations at two sites in rpoB,
one at aa 490 that involved a substitution of serine (S) for leucine
(L) (S490L, as in one of the previous mutants), and the other at
aa 617 that involved a substitution of serine (S) for phenylalanine
(F) (S617F).
To exclude the possibility that the observed phenotypic
changes were related to secondary mutations rather than the
mutations identified in rpoB, each of the mutations was cloned
into a plasmid (pMAD) and introduced into the WT strain
to generate a set of eight strains (seven with single mutations:
H485Y, H485C, H485R, H485D, S490L, Q472R and S617F, and
one with a double mutation: S490L/S617F) with mutations in
rpoB but that were otherwise isogenic with the WT strain.
Fortunately, all mutations, except S617F that was associated
with the double mutant and insufficient to confer resistance to
rifampicin, led to the Rifr phenotype (Table 1). All the mutations
that caused rifampicin resistance in vegetative B. velezensis CC09
cells were mapped to a rather restricted location within cluster I
of RpoB (Figure 1).
Subsequently, seven mutants, labeled CC09-RIF1 (H485Y),
CC09-RIF2 (H485C), CC09-RIF3 (H485R), CC09-RIF4
(H485D), CC09-RIF5 (S490L), CC09-RIF6 (Q472R), and CC09-
RIF7 (S490L/S617F), were studied in detail in the following
experiments.
Effects of Rifr Mutations on the Cell
Growth, Physiology, and Metabolism of
B. velezensis CC09
Multicellular Growth Pattern
Compared to the WT strain, all seven Rifr mutants exhibited
a different multicellular growth pattern (Figure 2). The
CC09-RIF2 (H485C), CC09-RIF3 (H485R), and CC09-RIF4
(H485D) strains had a mutation of the same histidine
residue (H485) and exhibited similar multicellular growth
patterns. However, the point mutation of the same residue
from histidine (H) to tyrosine (Y) (CC09-RIF1) caused an
intermediate phenotype (which was like the phenotypes of
both the WT strain and the other mutants containing H485
mutations). CC09-RIF6 (Q472R) exhibited a very smooth
multicellular growth pattern, while CC09-RIF7 (S490L/S617F)
exhibited a “powdery” multicellular growth pattern in the
same culture conditions. These results clearly indicate that
the mutations in the rpoB gene that confer resistance to
TABLE 1 | Point mutations in the rpoB gene of Bacillus velezensis that
confer Rifr.
Strain Nucleotide Amino acid Rifr Number∗
CC09 NA NA − NA
CC09-RIF1 C1453T H485Y + 2
CC09-RIF5 C1469T S490L + 2
CC09-RIF2 CA1453(4) TG H485C + 2
CC09-RIF3 A1454G H485R + 4
CC09-RIF4 C1453G H485D + 1
CC09-RIF6 A1415G Q472R + 2
CC09-RIF7 C1469T/C1850T S490L/S617F + 1
CC09-6I7F C1850T S617F − NA
∗Number of spontaneous mutants containing the same point mutation in rpoB
gene. CC09 is the WT strain of B. velezensis. + or – indicates the strain resistant
or sensitive to Rif. NA means not applied in the experiment.
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FIGURE 1 | Map of the Escherichia coli RNA polymerase β (RpoB) subunit. (Top) Location of Rif clusters I, II, and III. (Bottom) Amino acid sequence
alignment of the Rif clusters in E. coli, Staphylococcus aureus, Bacillus subtilis, Mycobacterium tuberculosis, and Bacillus velezensis. The numbering begins at the
first amino acid of the RpoB sequences. Well-characterized RpoB substitutions that cause rifampicin resistance in E. coli are noted above the E. coli RpoB
sequence. Closed triangles above the E. coli sequence indicate amino acid substitutions; empty triangles indicate amino acid deletions;  indicates amino acid
insertions; closed diamonds below the B. velezensis sequence indicate amino acid substitutions.
FIGURE 2 | Morphology of the multicellular growth patterns of the WT strain and Rifr mutants.
rifampicin dramatically altered the multicellular growth pattern
of B. velezensis.
Growth Rate
OD600 values were used to determine the specific growth rate of
the strains (Table 2). A slow specific growth rate in comparison
to the WT strain (p < 0.05) was exhibited by CC09-RIF7
(S490L/S617F). In contrast, the other Rifr mutants exhibited the
same specific growth rate as the WT strain (p > 0.05). In other
words, in the given culture conditions, the growth rate of all the
mutants with single point mutations in rpoB (i.e., H485Y, H485C,
H485D, H485R, S490L, Q472R, and S490L) were not significantly
affected. However, compared to the effect of S490L in CC09-
RIF5, the second mutation, S617F, in the double mutant CC09-
RIF7 (S490L/S617F) reduced the specific growth rate (p < 0.05).
The mechanism by which the single point mutation, S617F,
influences the phenotypes of B. velezensis and the mechanism
by which S490L and S617F interact will be explored in a future
study.
Swarming Motility
In terms of swarming motility, compared to WT strain
(15.5 mm/h), the Rifr mutants all exhibited weak swarming
motility when they were cultured on 0.7% GLB agar plates at
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TABLE 2 | Effects of the point mutations in the rpoB gene that confer Rifr.
Strain Mutation µ (OD/h) SM (mm/h) S50 (h) SGI (%) Iturin A (µg/ml) MIC (µg/mL)
CC09 - 0.94 ± 0.04a 15.5 ± 0.6a 34.2 71.8 ± 1.4c 168.1 ± 15.2c 0
CC09-RIF1 H485Y 0.86 ± 0.06a 7.6 ± 0.3c 58.8 52.5 ± 2.2 b 136.7 ± 9.5d 1024
CC09-RIF2 H485C 1.04 ± 0.09a 10.4 ± 0.5b 48.6 72.4 ± 2.2c 184.9 ± 6.7c 1024
CC09-RIF3 H485R 0.90 ± 0.03a 9.6 ± 0.7b 52.4 80.9 ± 1.2d 342.1 ± 10.1a 1024
CC09-RIF4 H485D 0.95 ± 0.06a 9.5 ± 0.6b 55.9 83.4 ± 2.6d 280.9 ± 3.6b 1024
CC09-RIF5 S490L 0.91 ± 0.04a 2.9 ± 0.2d 78.7 40.4 ± 1.1a 73.7 ± 5.8e 128
CC09-RIF6 Q472R 0.90 ± 0.06a 9.3 ± 0.4b 84.1 48.6 ± 2.3b 93.8 ± 5.2e 256
CC09-RIF7 S490L/S617F 0.66 ± 0.01b 2.7 ± 0.1d 50.3 44.1 ± 2.4a 134.9 ± 4.0d 128
Data in the table was presented as average value ± standard deviation (SD) of the values in three biological replicates, except the values of S50 and MIC; µ-specific
growth rate; SM-swarming motility; S50-the time of 50% vegetative cells formed spores which were calculated according to the sporulation curve in Supplementary Figure
S2; SGI-spore germination inhibition of Aspergillus niger; iturin A- Iturin A concentration in the culture; MIC-the minimum inhibitory concentration against the antibiotic
rifampicin. Different lowercase letters on each number define the test strains (triplicate sets) that showed significant differences (p < 0.05) in one-way ANOVA and Tukey’s
Multiple Comparison Test.
32◦C for 5 h (Table 2). CC09-RIF5 (S490L) (2.9 mm/h) and
CC09-RIF7 (S490L/S617F) (2.7 mm/h) exhibited the slowest
swarming motility, followed by CC09-RIF1 (H485Y) (7.6 mm/h),
and then CC09-RIF2 (H485C) (10.4 mm/h), CC09-RIF3 (H485R)
(9.6 mm/h), CC09-RIF4 (H485D) (9.5 mm/h), and CC09-RIF6
(Q472R) (9.3 mm/h).
Sporulation
The effect of the Rifr mutations on spore formation in
B. velezensis was complicated by the potential effects of both the
mutation site and the substituted aa. In general, the mutations
all greatly delayed sporulation compared to that of the WT
strain (Supplementary Figure S2). Based on the S50, the mutants
could be roughly grouped into four classes. Class I contained
two mutants [CC09-RIF5 (S490L) and CC09-RIF6 (Q472R)] with
S50 of 78.7–84.1 h; class II contained one mutant [CC09-RIF1
(H485Y)] with an S50 of 58.8 h; class III contained two mutants
[CC09-RIF3 (H485R) and CC09-RIF4 (H485D)] with S50 of
52.4–55.9 h; and class IV contained two mutants [CC09-RIF2
(H485C) and CC09-RIF7 (S490L/S617F)] with S50 of 48.6–50.3 h.
In contrast, the S50 of the WT strain was 34.2 h. These data
suggest that the Rifr mutations in rpoB have severe impacts on the
sporulation of B. velezensis, and potentially on the sporulation of
other Bacillus species.
Pellicle Formation
Based on unaided observations at 7 h after inoculation, we found
pellicle in the wells containing the WT strain and the CC09-
RIF3 (H485R), CC09-RIF4 (H485D), CC09-RIF2 (H485C),
and CC09-RIF1 (H485Y) mutants. However, the formation of
pellicle in the wells containing the CC09-RIF7 (S490L/S617F),
CC09-RIF6 (Q472R), and CC09-RIF5 (S490L) mutants was
significantly delayed to 11, 13, and 15 h post-incubation,
respectively.
Moreover, the appearance of the pellicle varied among
the Rifr mutants. For instance, the surface of the pellicle
of the CC09-RIF3 (H485R), CC09-RIF4 (H485D), CC09-RIF2
(H485C), and CC09-RIF1 (H485Y) mutants was quite wrinkled
FIGURE 3 | Appearance of the pellicle of the WT strain and Rifr mutants at 16 h after inoculation.
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and thick, while that of the CC09-RIF5 (S490L) and CC09-
RIF7 (S490L/S617F) mutants, as well as the WT strain, was
very smooth and thin (Figure 3). In addition, the weight of
the pellicle produced by the CC09-RIF2 (H485C) and CC09-
RIF4 (H485D) mutants was 6.0 mg and 2.8 mg, respectively,
which was significantly different from that of the WT strain
(4.5 mg) (Supplementary Figure S3). Due to the lower yield
of pellicle, it was difficult to evaluate the weight of the pellicle
produced by the CC09-RIF5 (S490L) and CC09-RIF6 (Q472R)
mutants. These results indicate that Rifr mutations in the
rpoB gene have important effects on pellicle formation in B.
velezensis.
Antifungal Activity
Based on the plate assay, the culture filtrate of the seven Rifr
mutants exhibited differences in their inhibition of A. niger spore
germination (Table 2). The CC09-RIF3 (H485R) and CC09-
RIF4 (H485D) mutants exhibited the highest antifungal activity
(they inhibited 80.87–83.43% of spore germination); followed
by CC09-RIF2 (H485C) (72.41%); CC09-RIF1 (H485Y) and
CC09-RIF6 (Q472R) (48.58–52.49%); and CC09-RIF5 (S490L)
and CC09-RIF7 (S490L/S617F) (40.36–44.09%). All the mutants
except for CC09-RIF2 (H485C) exhibited a significant change
(higher or lower) in their ability to inhibit spore germination
compared to the WT strain (p< 0.05) (Table 2).
Iturin A Production
The different inhibitory effects of the culture filtrate on fungal
spore germination are likely to be related to the level of iturin
A production. Indeed, the production of iturin A by Rifr
mutants was positively correlated (R2 = 0.76, p < 0.01) with
their antifungal activity (Table 2; Supplementary Figure S4).
The CC09-RIF3 (H485R) and CC09-RIF4 (H485D) mutants
produced a much larger quantity of iturin A compared to
the WT strain, while the CC09-RIF1 (H485Y), CC09-RIF6
(Q472R), CC09-RIF7 (S490L/S617F), and CC09-RIF5 (S490L)
mutants produced a significantly lower quantity of iturin A.
The CC09-RIF2 (H485C) mutant was not significantly different
compared to the WT strain in terms of iturin A production.
Moreover, different aa substitutions at the same site in RpoB also
significantly affected the production of iturin A. For instance,
the concentration of iturin A in the cultures of the CC09-RIF1
(H485Y), CC09-RIF2 (H485C), CC09-RIF4 (H485D), and CC09-
RIF3 (H485R) mutants (which had mutations at 485 that caused
a substitution of H for Y, C, D, and R, respectively) were 136.7,
184.9, 280.9, and 342.1 µg/mL, respectively.
Rifr mutations at different aa positions can have the same
effect on iturin A production. For example, the production of
iturin A did not differ significantly between CC09-RIF1 (H485Y)
and CC09-RIF7 (S490L/S617F), or between CC09-RIF5 (S490L)
and CC09-RIF6 (Q472R) (p > 0.05). However, the former pair
exhibited a significantly higher production compared to the latter
(p< 0.05). Moreover, by comparing the iturin A produced by the
CC09-RIF5 (S490L) and CC09-RIF7 (S490L/S617F) mutants, we
found that the S617F mutation had a significant compensatory
effect on the reduced production of iturin A caused by the S490L
mutation. These results suggest that mutations at different sites
in the rpoB alleles or different aa substitutions corresponding to
the same sites in the rpoB alleles influence iturin A production,
which may be due to different mechanisms.
MIC of Rifampicin
The four mutants with different aa substitutions at position 485
in RpoB [CC09-RIF1 (H485Y), CC09-RIF2 (H485C), CC09-RIF3
(H485R), and CC09-RIF4 (H485D)] had the highest degree of
rifampicin resistance among the seven Rifr mutants, with a MIC
of 1.024 mg/mL. In contrast, the mutation in the CC09-RIF5
(S490L) mutant and the mutation in the CC09-RIF6 (Q472R)
mutant led to relatively weak degrees of rifampicin resistance,
with a MIC of 0.128 and 0.256 mg/mL, respectively (Table 2).
Dendrogram of Hierarchical Clustering Based on the
Phenotypes
A clustering analysis of the data in Table 2 was carried
out to study the correlation between the Rifr mutations and
their corresponding phenotypes in B. velezensis CC09. When
the cutline height was set to 250, the mutants containing aa
substitutions at H485 were clustered into the same group, while
the strains with S490L and Q472R mutations, as well as the WT
strain, were clustered into another group (Figure 4). This result
indicates that H485 is a key aa in the RpoB of B. velezensis,
and any substitutions of this aa lead to a distinctive change
in morphology, physiology, and metabolism. Compared to the
H485 mutations, the S490L and Q472R mutations had relatively
weak impacts on the biological processes of B. velezensis, as the
strains with these mutations were clustered into the same group
as the WT strain.
When the cutline height was set to 150, the test strains
were clustered into five groups. Group 1 contained CC09-RIF1
(H485Y) and CC09-RIF2 (H485C), group 2 contained CC09-
RIF3 (H485R) and CC09-RIF4 (H485D), group 3 contained
CC09-RIF5 (S490L) and CC09-RIF7 (S490L/S617F), group 4
contained CC09-RIF6 (Q472R), and group 5 contained the WT
strain (Figure 4).
These results strongly suggest that the mutations in the rpoB
gene that cause resistance to rifampicin play important roles in
the regulation of the biological processes in B. velezensis.
Effects of Rifr Mutations on Gene
Expression
As the Rifr mutations in the rpoB gene (which encodes the
β subunit of RNAP) resulted in pleiotropic phenotypes in
B. velezensis, 15 genes that encode proteins associated with
antibiotic production and pellicle formation (Supplementary
Table S3) were selected for RT-qPCR analysis to identify the
potential correlation between the expression of the 15 genes and
the phenotypic changes. We carried out RT-qPCR using three
strains [i.e., WT, CC09-RIF3 (H485R), and CC09-RIF5 (S490L)].
Compared to the WT strain, the expression of four genes (i.e.,
abrB, pgdS, cheV, and sinI) was significantly up regulated in
both mutants [CC09-RIF3 (H485R) and CC09-RIF5 (S490L)].
Three genes (i.e., kinC, kinE, and yczE) were up regulated in
CC09-RIF3 (H485R) but unchanged in CC09-RIF5 (S490L),
while two genes (i.e., degS and degU) were downregulated in
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FIGURE 4 | Dendrogram of hierarchical clustering based on the phenotypes of the test strains.
TABLE 3 | Relative expression of 15 selected genes in the Rifr mutants
CC09-RIF5 (S490L) and CC09-RIF3 (H485R).
Gene CC09-RIF5 (S490L) CC09-RIF3 (H485R)
degS 0.32 ± 0.09 1.25 ± 0.47
degU 0.46 ± 0.04 1.62 ± 0.62
abrB 4.01 ± 0.82 2.02 ± 0.35
pgdS 3.36 ± 0.51 2.68 ± 0.33
cheV 8.23 ± 1.02 4.27 ± 0.04
kinC 1.88 ± 0.23 2.01 ± 0.10
kinE 0.72 ± 0.04 2.78 ± 0.22
yczE 0.63 ± 0.12 2.66 ± 0.54
ituA 0.67 ± 0.02 1.22 ± 0.12
ituB 0.82 ± 0.09 0.14 ± 0.01
srfAB 0.43 ± 0.03 0.24 ± 0.04
srfAA 1.48 ± 0.35 0.17 ± 0.08
sinI 3.23 ± 0.08 2.03 ± 0.25
sinR 1.56 ± 0.36 0.78 ± 0.02
spo0A 0.66 ± l.20 0.91 ± l.20
Data in the table was presented as average value ± standard deviation (SD) of the
value of three biological replicates.
CC09-RIF5 (S490L) but unchanged in CC09-RIF3 (H485R).
These results indicate that the mutations in RpoB had wide-
ranging effects on the transcription of the 15 functional genes
(Table 3).
Moreover, based on the hierarchical clustering analysis of
the relative expression of the 15 genes that were quantified
using RT-qPCR, when the cutline height was set to 140, we
found that CC09-RIF3 (H485R) belonged to an independent
group, while CC09-RIF5 (S490L) and the WT strain were
clustered into a separate group (Supplementary Figure S5). This
is consistent with the hierarchical clustering results based on
the phenotypes (Figure 2). These results demonstrate that the
pleiotropic phenotypes of the Rifr mutants were likely to be
caused by changes in the global transcriptional regulation of the
genes that exhibited differential expression.
DISCUSSION
The aim of this study was to isolate, sequence, and phenotypically
characterize several Rifr mutations in the rpoB gene of
B. velezensis, an endophytic bacterium with biocontrol properties.
We obtained six strains with single and one with a double
point mutation in rpoB that conferred resistance to rifampicin
(all of which were in the cluster I region of RpoB). These Rifr
mutations have been described in other bacteria, such as E. coli
(Jin et al., 1988b), S. lividans (Hu et al., 2002), B. subtilis (Ingham
and Furneaux, 2000), M. tuberculosis (Mokrousov et al., 2003),
and S. aureus (Wichelhaus et al., 1999). Moreover, these Rifr
mutations in B. velezensis influence a wide range of processes,
including cell growth, pellicle formation, swarming motility,
sporulation, and iturin A production, which might be a result of
the regulation of related genes.
Most of the Rifr mutations that have been identified thus
far map directly to the domain of, or regions adjacent to, the
rifampicin-binding pocket of the RpoB (Jin and Gross, 1988,
1991; O’Neill et al., 2000). The aa substitutions at D516, H526,
and S531 (using the E. coli RpoB numbering system) frequently
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confer high levels of resistance to refamipicin in Rifr mutant
clinical isolates (Alifano et al., 2015). Among the 14 Rifr mutants
sequenced in this study, eight (57.1%) had aa substitutions at
H485, and two (14.3%) had aa substitutions at S490, which
correspond to homologous substitutions at H526 and S531,
respectively, in E. coli RpoB (Table 1). These results suggest that
the frequency of Rifr mutations in the rpoB gene of B. velezensis
was probably similar to that in other bacteria such as E. coli. In
addition, all the aa substitutions at H485 in RpoB of B. velezensis
led to the highest MIC of rifampicin among the test strains
(Table 2), which is consistent with the findings of a study by
Alifano et al. (2015).
The substitution of the glutamine (Q), histidine (H), and
serine (S) residues in the cluster I region of RpoB (Q513, H526,
and S531 in E. coli; Q469, H482, and S487 in B. subtilis; Q472,
H485, and S490 in B. velezensis) are the most effective mutations
in terms of the promotion adaptive responses. They cause global
changes in the bacteria, such as alternative substrate utilization,
secondary metabolism, sporulation/germination, and antibiotic
heteroresistance (Zhou and Jin, 1998; Maughan et al., 2004;
Alifano et al., 2015). However, the effects of Rifr mutations on
phenotypes vary both within and between bacterial species. For
instance, compared to the WT strain, the S487L mutation in
the rpoB gene of B. subtilis led to a lower specific growth rate,
while Q469R and H482R/Y mutations did not affect the growth
of the strain when it was cultured in LB medium (Maughan
et al., 2004). The Q469R and S487L mutations dramatically
inhibited sporulation while H482R/Y exhibited a weak impact or
no impact on spore formation in B. subtilis (Moeller et al., 2012).
In this study, almost all of these mutations (Q469R, S487L, and
H482R/Y) in B. velezensis exhibited inhibitory effects on spore
formation.
Interestingly, we isolated a B. velezensis CC09 strain with a
double point mutation (CC09-RIF7), which had S490L and S617F
substitutions in RpoB. Although the S617F mutation found in the
double mutant CC09-RIF7 was not sufficient to confer resistance
to rifampicin, it exhibited compensatory effects on the phenotype
defects (e.g., defects in pellicle formation, sporulation, and iturin
A production) caused by the S490L mutation. This was probably
due to a functional or structural interaction between the two sites
(Jin and Gross, 1988).
According to the classification system proposed by Alifano
et al. (2015), the Rifr mutations in the cluster I region of RpoB
of B. velezensis can be clustered into three groups: (i) H485
mutations that lead to a decrease in transcription termination;
(ii) Q472 mutations that result in an increase in transcription
termination; and (iii) S490 mutations that cause a decrease
in antitermination. This classification is relatively consistent
with the dendrograms of hierarchical clustering based on the
phenotypes (Figure 4) and the relative expression of the 15
functional genes (Supplementary Figure S5) that we observed.
Mutants with substitutions in RpoB at aa position H485 (H485Y,
H485C, H485R, and H485D) were classified into a group with
a high level of iturin A production and increased inhibition of
fungal spore germination. In fact, several studies on multiple
species revealed that H485 mutations are closely associated with
the initiation of, and increase in, antibiotic production (Ingham
and Furneaux, 2000; Hu et al., 2002; Wang G. et al., 2008; Tanaka
et al., 2013). We intend to explore the correlations between the
phenotypes (e.g., pellicle formation, sporulation, and iturin A
production) and gene expression in a future study.
The effect of the Rifr mutations on antibiotic production
is dependent on the type of antibiotic and bacterial species.
For example, the Rifr mutations H437R and S442L significantly
enhance the production of streptomycin by S. griseus (Tanaka
et al., 2013), while homologous mutations inhibit the production
of iturin A in B. velezensis. The H439R/D mutations in RpoB
increase the production of erythromycin, while Q426R reduces
the production of erythromycin in Saccharopolyspora erythraea
(Carata et al., 2009). These mutations (i.e., H485R/D and Q472R)
had similar effects in B. velezensis CC09 with respect to iturin A
production (Table 2).
In order to understand the possible relationship between
iturin A production and gene expression, we performed an
RT-qPCR analysis of two genes, ituA and ituB in the iturin
A operon, which encode synthetases in CC09-RIF3 (H485R),
CC09-RIF5 (S490L), and WT strains of B. velezensis. Surprisingly,
the production of iturin A (Table 2) was inconsistent with
the expression of ituA and ituB in the mutants (Table 3).
However, the relative expression of yczE, which encodes an
integral membrane protein, in the CC09-RIF3 (H485R) strain
was significantly higher than that in the CC09-RIF5 (S490L)
and WT strains. YczE has been reported to be a candidate for
anchoring the synthetases at the membrane and enhancing the
production of bacillomycin D, which belongs to the iturin A
family (Koumoutsi et al., 2007). Thus, the production of iturin A
by B. velezensis may be regulated at the post-transcriptional stage
(Koumoutsi et al., 2007).
Mature pellicles are embedded in an extracellular polymeric
matrix, which is composed of exopolysaccharides, proteins,
adhesins, and, occasionally, DNA (Luary et al., 2014). They
have a significant impact in medical, industrial, and agricultural
settings; for example, they can enhance bacterial colonization of
plants (Hallstoodley et al., 2004). Many extracellular metabolites
such as surfactants (e.g., iturins and surfactins), polysaccharides,
γ-polyglutamic acid (PGA), and proteins (e.g., CheV) are
associated with pellicle formation.
The formation of pellicles is mainly regulated via Spo0A/AbrB,
SinI/SinR, and DegS/DegU regulatory systems in Bacillus
species (Chu et al., 2008; Wang et al., 2015). Our RT-qPCR
data (based on the analysis of 15 genes associated with
antibiotic production and pellicle formation) also provided
evidence that these regulatory systems play important roles
in the formation of pellicle in B. velezensis CC09. For
instance, the relative expression of abrB and sinI, which
negatively regulate the expression of genes related to extracellular
polysaccharide synthetases, dramatically increased in both the
CC09-RIF3 (H485R) and CC09-RIF5 (S490L) mutants, leading
to a defect in pellicle formation. The delayed formation and
decreased biomass of pellicle in CC09-RIF5 (S490L) may
have been caused by down regulation of the expression of
degS and degU. This may in turn have resulted in a higher
expression of pgdS (Table 3) and, consequently, a reduction
in γ-PGA. It has reported that the production of γ-PGA
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is positively regulated by DegU/DegS and negatively regulated
by PgdS (Ohsawa et al., 2009; Scoffone et al., 2013). Therefore,
we speculate that the more severe defect in pellicle formation in
CC09-RIF5 (S490L) compared to CC09-RIF3 (H485R) resulted
from the down regulation of degS and degU together with the up
regulation of abrB and cheV.
Compared to the WT strain, the Rifr mutants exhibited
various multicellular growth patterns (Figure 2). It has been
reported that the formation of multicellular growth patterns
is an exceptionally complex process (e.g., it involves cell–cell
interaction, communication via chemotaxis signaling, and
swarming motility) that requires the regulation of many genes at
all levels of gene regulation (Martínez and Vadyvaloo, 2014). For
example, the DegS/DegU regulatory system has been reported
to control a variety of cell phenotypes, including extracellular
protein production, swarming motility, pellicle formation, and
the formation of complex structures based on multicellular
growth patterns (Verhamme et al., 2007, 2009). The down
regulation of degS and degU in the CC09-RIF5 (S490L) strain
might have led, at least in part, to the morphological change
in its multicellular growth pattern compared to the WT strain.
However, the morphological change in the multicellular growth
pattern of CC09-RIF3 (H485R) was not due to a change in
degS/degU expression (Table 3), which indicates that bacterial
multicellular growth patterns are regulated by more than one
regulatory system. However, further studies are required to
elucidate how the Rifr mutations lead to changes in the
multicellular growth patterns of B. velezensis.
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